Aurinia Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Operational Highlights

February 24, 2021
Aurinia Pharmaceuticals Inc.

February 24, 2021 – VICTORIA, British Columbia–(BUSINESS WIRE)– Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (“Aurinia” or the “Company”) today issued its financial results for the fourth quarter and year ended December 31, 2020. Amounts, unless specified otherwise, are expressed in U.S. dollars. “Over the past year, Aurinia matured into a fully-integrated biopharmaceutical company … Continue reading Aurinia Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Operational Highlights

How a Canadian firm is accelerating the development of therapeutics

February 23, 2021
AbCellera Biologics Inc.

February 23, 2021 – Innovative Canadian companies are harnessing the power of sophisticated digital technologies to develop effective therapeutics in entirely new ways. This work involves advanced research at the nexus of multiple disciplines, including microbiology, biochemistry and computer science. The tremendous value of this research became apparent during COVID‑19 with the rapid development and production … Continue reading How a Canadian firm is accelerating the development of therapeutics

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Year-End 2020 Financial Results

February 23, 2021
Xenon Pharmaceuticals Inc.

BURNABY, British Columbia, Feb. 23, 2021 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today announced it will report its 2020 financial and operating results after the close of U.S. financial markets on Monday, March 1, 2021: Xenon management will host a conference call and live audio webcast at 4:30 pm … Continue reading Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Year-End 2020 Financial Results

Xenon Pharmaceuticals Announces Promising New Pre-Clinical Data and Provides Clinical Overview of its XEN1101 Program at ASENT 2021

February 22, 2021
Xenon Pharmaceuticals Inc.

BURNABY, British Columbia, Feb. 22, 2021 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, announced that new pre-clinical data and a clinical overview of its XEN1101 program will be presented at ASENT 2021, the virtual annual meeting of the American Society for Experimental Neurotherapeutics. XEN1101 is a differentiated Kv7 potassium channel modulator … Continue reading Xenon Pharmaceuticals Announces Promising New Pre-Clinical Data and Provides Clinical Overview of its XEN1101 Program at ASENT 2021

LifeSciences BC’s 6th Annual Access to Innovation Conference will generate important conversation between R&D, Academia, Industry and Government

February 22, 2021
LifeSciences BC

VANCOUVER, B.C., February 22, 2021 – A compelling and critical conversation will unfold over a two-day period at LifeSciences BC’s 6th ANNUAL ACCESS TO INNOVATION. The conference, virtual this year, on February 24 – 25, 2021, will host thought leaders from health research & innovation, academia, industry, and government as well as, key individuals in … Continue reading LifeSciences BC’s 6th Annual Access to Innovation Conference will generate important conversation between R&D, Academia, Industry and Government

Northview LifeSciences Invests in Elevate Farms

February 18, 2021
Northview LifeSciences

Februrary 18, 2021 – Northview LifeSciences is pleased to announce the closure of our $1 million investment into Elevate Farms Inc. as part of their $6.2 million financing. Concurrent with this financing, our Managing Director Doug Janzen will be joining the Elevate board. Northview is proud to add Elevate Farms to our portfolio, making it … Continue reading Northview LifeSciences Invests in Elevate Farms

Aurinia Pharmaceuticals to Present at the SVB Leerink 10th Annual Global Healthcare Conference

February 18, 2021
Aurinia Pharmaceuticals Inc.

VICTORIA, British Columbia–(BUSINESS WIRE)– Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that members of the executive management team will participate in a fireside chat at the (virtual) SVB Leerink 10th Annual Global Healthcare Conference on Thursday, February 25, 2021 at 1:00 p.m. ET. In order to participate in the audio webcast, … Continue reading Aurinia Pharmaceuticals to Present at the SVB Leerink 10th Annual Global Healthcare Conference

Praxis Announces the launch of the Praxis SCI Ideation Challenge

February 17, 2021
Praxis Spinal Cord Institute

February 17, 2021 – Do you have an idea to improve the lives of people living with spinal cord injuries (SCI)? Do you want help developing one? Do you need some seed funding to get your prototype developed? The Praxis Spinal Cord Injury (SCI) Ideation Challenge is a roadmap to helping you develop potentially commercializable … Continue reading Praxis Announces the launch of the Praxis SCI Ideation Challenge

Kintara Therapeutics Enrolls Final Patient in Phase 2 Clinical Trial of VAL-083 for Recurrent GBM

February 17, 2021
Kintara Therapeutics, Inc.

SAN DIEGO, Feb. 17, 2021 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced it has enrolled the final patient in the recurrent arm of its ongoing Phase 2 clinical study of VAL-083 being conducted at the MD Anderson … Continue reading Kintara Therapeutics Enrolls Final Patient in Phase 2 Clinical Trial of VAL-083 for Recurrent GBM

Aurinia Pharmaceuticals to Release Fourth Quarter and Year End 2020 Financial Results on February 24, 2021

February 17, 2021
Aurinia Pharmaceuticals Inc.

VICTORIA, British Columbia–(BUSINESS WIRE)– Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that it will release its fourth quarter and year end 2020 financial results on Wednesday, February 24, 2021, after the markets close. Aurinia’s management team will host a conference call to discuss the Company’s financial results and to provide … Continue reading Aurinia Pharmaceuticals to Release Fourth Quarter and Year End 2020 Financial Results on February 24, 2021